metricas
covid
Buscar en
Cirugía Española (English Edition)
Toda la web
Inicio Cirugía Española (English Edition) Response to “Is percutaneous cholecystostomy in acute cholecystitis safe and e...
Información de la revista
Vol. 99. Núm. 9.
Páginas 698-699 (noviembre 2021)
Vol. 99. Núm. 9.
Páginas 698-699 (noviembre 2021)
Letter to the Editor
Acceso a texto completo
Response to “Is percutaneous cholecystostomy in acute cholecystitis safe and effective? Analysis of the adverse effects associated with the technique”
Respuesta a: «¿Es segura y eficaz la colecistostomía percutánea en la colecistitis aguda? Análisis de los efectos adversos asociados a la técnica»
Visitas
409
German Eduardo Rueda-Merchána, María Manuela Rodríguez-Gutiérrezb,
Autor para correspondencia
manu.rodriguezg2097@gmail.com

Corresponding author.
, María Carolina Díaz-Riverab
a Future Surgeons Chapter, Colombian Surgery Association, Bogotá, Colombia
b Semillero de investigación en Ciencias Médicas y Quirúrgicas, Facultad de Medicina, Fundación Universitaria Autónoma de las Américas, Pereira, Colombia
Este artículo ha recibido
Información del artículo
Texto completo
Bibliografía
Descargar PDF
Estadísticas
Texto completo
Letter to the Editor:

We have read with great interest the article published by Bejarano González et al.1 “Is Percutaneous Cholecystostomy in Acute Cholecystitis Safe and Effective? Analysis of the Adverse Effects Associated with the Technique”. We appreciate the results of the study, in which the authors declare that percutaneous cholecystostomy is a safe and effective technique because it is associated with a low incidence of adverse events and mortality, and should be considered as a bridge therapy or definitive alternative in patients who are not candidates for urgent cholecystectomy after the failure of conservative antibiotic treatment1. However, we would like to add some comments and share our experience in Colombia with the arrival of COVID-19.

As stated by Bejarano González et al.1, percutaneous cholecystostomy is a resource that the treating physician can make use of when dealing with patients with acute cholecystitis who are not candidates for urgent surgery, have shown poor evolution with antibiotic management, or have comorbidities that increase the risk of subjecting the patient to an invasive procedure. This is also discussed in the recommendations proposed by the Tokyo guidelines, which are used worldwide for the management of patients with cholecystopathies2.

With the arrival of the SARS-CoV-2 pandemic in Colombia, medical centers started to see an increase in the cancellation of elective surgeries, including cholecystectomies. However, surgical emergencies at the beginning of the pandemic (March 2019) continued to arrive, so the Colombian Association of Surgery published recommendations for the management of patients with urgent surgical disease. These guidelines recommended early cholecystectomy in patients with ASA I or II cholecystopathies with Tokyo I or II, acute cholecystitis, thereby seeking to reduce prolonged hospitalizations, optimize institutional resources and reduce the risk of nosocomial infection3,4.

Despite health campaigns to educate the population about COVID-19, the fear of patients of becoming infected in hospitals increased the time between the onset of symptoms, diagnosis, and timely management of acute cholecystitis, which led to an increase in patients with acute cholecystitis and organ dysfunction or Tokyo III. This resulted in an increased use of percutaneous or open cholecystostomies according to the availability of hospital resources in patients who did not progress favorably with antibiotic therapy or had an ASA classification greater than or equal to III, following the recommendation of the Colombian Association of Surgery for the management of patients with urgent surgical disease2,3.

Finally, we would like to thank the authors for the data provided in their study regarding the safety of the percutaneous cholecystostomy technique. It invites surgeons to use this procedure as a safe and effective alternative in patients who are not candidates for cholecystectomy as an initial treatment measure, which affects the morbidity and mortality of patients with acute cholecystitis. It will also help us propose a similar descriptive observational study in our country.

References
[1]
N. Bejarano González, A. Romaguera Monzonís, P. Rebasa Cladera, N. García Monforte, M. Labró Ciurans, J. Badia Closa, et al.
Is percutaneous cholecystostomy safe and effective in acute cholecystitis? Analysis of adverse effects associated with the technique.
Cir Esp., (2021),
[2]
M. Yokoe, J. Hata, T. Takada, S.M. Strasberg, H.J. Asbun, G. Wakabayashi, et al.
Tokyo guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos).
J Hepatobiliary Pancreat Sci., 25 (2018), pp. 41-54
[3]
L. Cuevas-López, J.C. Ayala Acosta, O.A. Velásquez-Jiménez, J.A. Navarro-Alean, L.G. González-Higuera, N. Zurita Medrano, et al.
Recomendaciones para el manejo de los pacientes quirúrgicos urgentes durante la pandemia COVID-19.
Rev Colomb Cir., 35 (2020), pp. 143-152
[4]
L. Torregrosa, R. Prieto, L.F. Cabrera, J. Ordoñez, E. Sánchez, C. Rodríguez, et al.
Recomendaciones generales para los Servicios de Cirugía en Colombia durante la pandemia COVID-19 (SARS-CoV-2).
Rev Colomb Cir., 35 (2020), pp. 264-280

Please cite this article as: Rueda-Merchán GE, Rodríguez-Gutiérrez MM, Díaz-Rivera MC. Respuesta a: «¿Es segura y eficaz la colecistostomía percutánea en la colecistitis aguda? Análisis de los efectos adversos asociados a la técnica». Cir Esp. 2021;99:700–701.

Copyright © 2021. AEC
Descargar PDF
Opciones de artículo
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos